Background: Preterm infants having immature lungs often require respiratory support, potentially leading to bronchopulmonary dysplasia (BPD). Conventional BPD rodent models based on mechanical ventilation (MV) present outcome measured at the end of the ventilation period. A reversible intubation and ventilation model in newborn rats recently allowed discovering that different sets of genes modified their expression related to time after MV. In a newborn rat model, the expression profile 48 h after MV was analyzed with gene arrays to detect potentially interesting candidates with an impact on BPD development. Methods: Rat pups were injected P4-5 with 2 mg/kg lipopolysaccharide (LPS). One day later, MV with 21 or 60% oxygen was applied during 6 h. Animals were sacrified 48 h after end of ventilation. Affymetrix gene arrays assessed the total gene expression profile in lung tissue. results: In fully treated animals (LPS + MV + 60% O 2 ) vs. controls, 271 genes changed expression significantly. All modified genes could be classified in six pathways: tissue remodeling/ wound repair, immune system and inflammatory response, hematopoiesis, vasodilatation, and oxidative stress. Major alterations were found in the MMP and complement system. conclusion: MMPs and complement factors play a central role in several of the pathways identified and may represent interesting targets for BPD treatment/prevention.
B
ronchopulmonary dysplasia (BPD) is a chronic lung disease occurring in ~30% of preterm infants born less than 30 wk of gestation (1) . Its main risk factors include lung immaturity due to preterm delivery, mechanical ventilation (MV), oxygen toxicity, chorioamnionitis, and sepsis. The main feature is an arrest of alveolar and capillary formation (2) . Models trying to decipher genes involved in the pathophysiology of BPD are mainly based on MV and oxygen application to young mammals with immature lungs of different species (3) . In newborn rodent models, analyses of lung structure and gene and protein expression are performed for practical reasons directly at the end of MV (4) (5) (6) . However, later appearing changes of gene expression might also have an impact on lung development and the evolution towards BPD and cannot be discovered by such models. Recently, we developed a newborn rat model of MV using an atraumatic (orotracheal) intubation technique that allows the weaning of the newborn animal off anesthesia and MV, the extubation to spontaneous breathing, and therefore allows the evaluation of effects of MV after a ventilationfree period of recovery (7) . Indeed, applying this concept of atraumatic intubation by direct laryngoscopy, we recently were able to show significant differences between gene expression changes appearing directly after MV compared to those measured after a ventilation-free interval of 48 h. Immediately after MV, inflammation-related genes showed a transitory modified expression, while another set of more structurally related genes changed their expression only after a delay of 2 d (7). Lung structure, analyzed by conventional 2D histology and also by 3D reconstruction using synchrotron x-ray tomographic microscopy revealed, 48 h after end of MV, a reduced complexity of lung architecture compared to the nonventilated rat lungs, similar to the typical findings in BPD. To extend these observations about late gene expression modifications, we performed with a similar model a full gene expression profile of lung tissue 48 h after the end of MV with either room air or 60% oxygen. Essentially, we measured changes in the expression of genes related to the MMPs and complement system which played a role in many of the six identified mostly affected pathways.
RESULTS

Mechanical Ventilation Experiments and Weight Gain
In preliminary experiments, we defined ventilation parameters in order to keep blood gas values within the physiologic range ( Table 1) . To measure rat pup's well-being during and after the ventilation episode, arterial blood was collected after 1 or 6 h of MV, and blood gases were analyzed. All animals tested showed normal values of pH, PcO 2 , Po 2 (except for hyperoxia in animals ventilated with 60% oxygen; Table 2 ). Weight gain per day was of 15 ± 4%. There was no difference before and after the treatment in all groups. During the days of intervention, daily weight gain was slightly reduced with 6 ± 6% in animals submitted to lipopolysaccharide (LPS) and MV.
Gene Arrays
Results of the gene array experiments were expressed as fold changes between the four groups: controls without LPS injection and ventilation (CTRL), LPS-injected (LPS), LPS-injected + ventilated with room air (LMV), and LPS-injected + ventilated with 60% oxygen (LMVO) animals. Comparisons were made either step by step between the four groups (LPS vs. CTRL, LMV vs. LPS, LMVO vs. LMV), between LMVO and LPS, or overall between the full treatment and the control group (LMVO vs. CTRL). In the step by step analysis, 195 genes showed a statistically significant over or underexpression between the LPS and the CTRL group, 17 genes between the LMV and the LPS group and 11 between the LMVO and the LMV group. When analyzing the genes with a modified expression between LMVO and LPS (altogether 15 genes; Supplementary Table S1 online), three major gene expression patterns were observed across the three treatments (LPS, LMV, LMVO): a constant decrease between the LPS to LMV and the LMV to LMVO group (in 40% of the genes), a constant increase (in 20%), or only an effect of MV without any effect of oxygen (27%).
The overall comparison between the LMVO and the CTRL group retrieved 271 genes with statistically significant expression changes (208 upregulated and 63 downregulated; Supplementary Table S2 online). Classification of these genes according to their expression profile across treatment groups defined six major patterns (Figure 1) . The first pattern represented genes with a progressive decrease in expression across treatments (5% of genes; Figure 1a) . The other five patterns all showed a first increase in gene expression probably due to LPS application (Figure 1b-f) . In 38% of these genes, no further effect of any additional treatment was observed (Figure 1d) . In 22%, an effect, either positive (16%; Figure 1f ) or negative (6%; Figure 1b ), could be attributed to MV without any further effect of oxygen. In 11% of the genes, an increased expression was observed due to oxygen with (in 5%; Figure 1c ) or without (in 6%; Figure 1e ) an associated downregulatory effect of MV.
Analyzing these genes through Metacore software, we identified six pathway folders that were significantly altered. These folders included (i) the immune system response, (ii) the inflammatory response, (iii) hematopoiesis, (iv) vasodilation, (v) oxidative stress regulation, and (vi) tissue remodeling/ wound repair (Figure 2) . Pathways related to the immune system response included the three complement pathways (classical, lectin induced, and alternative) with an increased expression of complement components C1s, C1qa, C1qb, C3aR1, and C4-2 genes, the transcription regulation of granulocyte development with an increased expression of CD45/PTPRC (a signaling molecule), myeloblastin (a serine protease), and granulocyte colonystimulating factor (G-CSF) receptor genes, and IL-12 signaling pathway with an increased expression of IL-12 receptor b2, STAT4, and perforin, a cytolytic protein secreted by cytotoxic T-lymphocyte genes. Pathways related to the inflammatory response folder were essentially the bradykinin/kallidin maturation, with an increased expression of kininogen 1 gene, the precursor of the vasodilator bradykinin, and G-CSF-induced myeloid differentiation with an increased expression of integrin alpha M (Itgam) (a regulating molecule of leukocyte migration and adhesion), G-CSF receptor, myeloblastin, and lipocalin-2/ NGAL genes. Genes related to hematopoiesis included G-CSF-induced myeloid differentiation and the transcription regulation of granulocyte development. The vasodilation pathway folder highlighted the bradykinin/kallidin maturation pathway while the oxidative stress regulation pathway folder was related to glutathione metabolism, exemplified by the increased expression of glutathione-S-transferase GSTA5 which is responsible for the detoxification of the cell notably from products of oxidative stress. Finally, the tissue remodeling and wound repair pathway folder comprised cell matrix glycoconjugates and extracellular matrix (ECM) remodeling pathways. Cell matrix glycoconjugates were related to an increased expression of l-selectin gene, a cell adhesion molecule found essentially on lymphocytes, MMP9, and CCL5/ RANTES chemokine genes. ECM remodeling was related to an increase in MMP9 gene expression, in association with an increase in TIMP1 gene (tissue inhibitor of metalloproteinases) and a decrease in MMP12 gene expression. MMP9 and MMP12 are matrix metalloproteinases which mainly process gelatin and collagen IV-V (MMP9) and elastin, fibronectin, and collagen IV (MMP12).
Processes highlighted in the analysis of our results through Metacore software are listed in Table 3 . These processes were linked to the immune system response, inflammatory response, hematopoiesis, iron transport, proteolysis (in relation with ECM remodeling or connective tissue degradation), and blood coagulation.
Quantitative RT-PCR Verification
In order to confirm gene array results, a series of candidate genes were evaluated by quantitative RT-PCR and compared to Articles Dénervaud et al.
the gene array data (Figure 3) . For all of them, the gene expression changes observed by qRT-PCR were consistent with the gene array results.
Proteins of Tissue Remodeling and Wound Repair Pathway Folder
Some genes, highlighted both by pathways and processes, were further evaluated at the protein level: MMP9, MMP12, TIMP1, and lipocalin-2/NGAL (Figure 4) . Indeed, MMP9-lipocalin-2 complex was 3.09 ± 0.46-fold higher in the LMVO group compared to the CTRL group (P = 0.01). MMP12 protein expression was 0.42 ± 0.08-fold lower in the LMVO compared to the CTRL group (P = 0.002) and lipocalin-2/NGAL 2.37 ± 0.29-fold higher in LMVO compared to CTRL group (P = 0.009). Conversely, TIMP1, whose mRNA expression was increased in the LMVO compared to the CTRL group, showed a lower protein expression in the LMVO group (0.68 ± 0.11-fold vs. CTRL; P = 0.039; Figure 4c ).
DISCUSSION
To better understand the molecular pathways involved in the development of BPD, we recently developed a newborn rat model enabling us to analyze late effects of inflammation, oxygen, and MV. Thanks to an atraumatic intubation procedure performed under direct laryngoscopy, we were able to wean ventilated newborn rats off anesthesia and MV which allowed us then to perform outcome measurements after a chosen time period of recovery (7) . In addition to the transitory increase of proinflammatory cytokines/chemokines measured in different studies immediately after MV and/or hyperoxia exposure in immature lungs (4, 8, 9) , our previous study demonstrated changes in MMP9 and tropoelastin mRNA expression only as a delayed reaction 48 h after the ventilation episode (7). This indicated a second wave of gene regulation that could correspond to mechanisms occurring in premature infants developing BPD. Therefore, we analyzed the complete gene expression profile in lungs of newborn rats 48 h after ventilation using gene arrays.
Tissue remodeling/wound repair was found to be one of the mostly affected pathway folders. It consists of a network of proteases/antiproteases including MMP9, MMP12, TIMP1, MMP8, secretory leukocyte peptidase inhibitor, and ADAM metallopeptidase with thrombospondin type 1 motif, 5 (ADAMTS5). The function of MMP9, also called gelatinase B, has been studied in lung development and lung inflammatory diseases such as BPD (3, 10) . Levels of MMP9 are increased in animal models of BPD (11) (12) (13) . MMP9 has been shown to be involved in ventilator-and oxygen-induced lung injury and has a potential for destruction of lung matrix and basement membrane (14) . MMP9 knockout mice showed increased survival and less important modifications of lung structure after hyperoxia exposure compared to wild-type animals (15) . Furthermore, MMP9/TIMP1 ratio has been shown to be elevated in tracheal aspirates of preterm infants who developed BPD (16, 17) . In our experiments, changes in MMP9 protein expression were synergistic with changes in other genes and proteins of the same pathway. Indeed, the increased MMP9 expression in LMVO (LPS-injected animals + ventilation with 60% oxygen) compared to CTRL group was associated to a decrease in TIMP1 expression, its principal inhibitor. A further increase of MMP9 activity could be expected from the observed increase in lipocalin-2/NGAL protein, which is able to bind MMP9 and inhibit its degradation. The increase in the complex formed by MMP9 and lipocalin-2 in the LMVO group was confirmed by MMP9 western blots, under the form of a 125 kDa band (Figure 4) (18,19) . Lipocalin-2/NGAL has been shown to be increased in serum and bronchoalveolar lavage fluid of premature infants developing BPD, and its level was associated with the risk of BPD development in a multivariate analysis (20, 21) . Taken together, these results suggest a combined effect toward an increase of MMP9 activity in ventilated immature lungs.
In our previous experiments, we had shown that elastin protein expression was unchanged in ventilated lungs after 48 h, whereas the mRNA expression of tropoelastin gene was decreased (7) . Several enzymes control elastin metabolism, like neutrophil elastase, alpha-1 antitrypsin, lysyl oxidase or the elastin binding protein. In our gene array, the macrophage elastase MMP12 was downregulated in the LMVO group, also (22, 23) . Both neutrophil and macrophage elastases have been associated with lung injury (24) . Our results confirm recently published experiments showing that prolonged ventilation with 40% oxygen increased MMP9 and elastase activity, resulting in elastin degradation and emphysematous alveoli, similar to findings in BPD. Treatment with the elastase inhibitor elafin showed promising reduction of these alterations (6, 25) . Similar to pediatric with acute respiratory distress syndrome (ARDS) patients, in which higher MMP9 and MMP8 activity in tracheal aspirates was correlated with a longer need for MV (26) , an increase in MMP8 in bronchoalveolar lavage fluid and lung tissue of rodents was observed after exposure to high-pressure ventilation or prolonged (48 h) high oxygen exposure (27) . Inactivation of MMP8 by a selective inhibitor resulted in less lung injury in a model of MV (28) . Therefore, the fact that our gene array experiments identified an increase of MMP8 gene expression 48 h after MV might also point to MMP8 as an interesting target to reduce negative effects of MV and oxygen.
MMPs have been discovered due to their role in ECM degradation. Since then, they have been assigned many other roles notably in inflammation, innate immunity, embryogenesis, wound healing, cell invasion, and angiogenesis (29-32). Indeed, MMPs are able to alter the activity of other proteases, liberate ECM-bound bioactive fragments and proteins (e.g., vascular endothelial growth factor or transforming growth factor-β), activate or inactivate many chemokines, exert membrane shedding activity, convert matrix proteins in bioactive signaling molecules, release active proteins from inhibitory complexes (e.g., vascular endothelial growth factor), or expose sites with biological activity by proteolytic cleavage of ECM proteins (30) (31) (32) . This indicates that substrates of MMPs are much more numerous than initially thought. For example, MMP9, which is secreted from neutrophils following IL-8 stimulation, was shown to cleave IL-8 chemokine and to increase its chemoattractant potency by 10-fold. MMP8 is required for CXCL6 neutrophil-recruiting chemokine activation. Finally, MMP12 plays a role in the regulation of the immune response duration by cleaving and inactivating a large number of chemokines to stop neutrophil/macrophage recruitment at the site of infection, by direct inhibition of the production of some proinflammatory cytokines and by disrupting the attachment of chemokines to the ECM or cell membrane (31, 33) . Therefore, the observed gene and protein expression changes in the MMP family may have an important impact on lung development and its deviation toward BPD by different mechanisms and pathways. Or in other words, regulating MMP activity might open new strategies to protect ventilated lungs from ventilator-and oxygen-induced lung injury. Many of the observed gene expression changes were involved in pathways related to the immune system, the inflammatory response, and hematopoiesis. In our previous experiments, we had found that the cytokines/chemokines whose gene expression was increased immediately after MV had returned to basal values when evaluated 48 h after end of ventilation (7). Indeed, in the present study, we confirm that the cytokine gene expression was normalized by 48 h. In fact, other genes than the cyto-/chemokines showed changes in gene expression leading to alteration of immune response and inflammation. In particular, we found that the immune system response was still or de novo stimulated at 48 h through the increased expression of many components of the complement system (C1s, C1qa, C1qb, while C3, C3aR, and C4-2). Several studies have shown a correlation between complement activation and ventilator-induced lung injury. Notably in rats, MV was shown to stimulate complement activity and its extravasation into lung tissue resulting in increased vascular permeability, which is one of the hallmarks of ventilator-induced lung injury (34). Takahashi et al. (35) found an increase in thrombin and MMP activity in bronchoalveolar lavage fluid of mice after MV which was not observed in C3-null mice or when wild-type mice were pretreated with a C3 inactivator. In human, polymorphisms in mannose-binding lectin 2, from the lectin-induced complement pathway, inducing a reduction of its expression were associated with lower ventilation duration and a decreased risk to develop BPD (20) . A study by Tsai et al. (36) investigating cytokine and complement kinetics in patients undergoing esophageal surgery showed an increase in IL-6 immediately after surgery and an increase in the complement protein C3a only 2 d after the end of surgery. Together, these studies are in accordance with our findings, showing that many factors of the complement complex, which have been linked to ventilator-induced lung injury and BPD, showed a prolonged or delayed upregulation and could constitute other interesting targets for treatment and/or prevention of BPD.
The step-by-step analysis between treatment groups highlighted a leading role for LPS in the effects obtained. Indeed, 195 genes showed an altered mRNA expression after LPS, compared to 17 and 11 after additional ventilation and oxygen treatment, respectively. This occurred despite the reduction of the amount of LPS of 33% compared to the dose used in three previous similar studies (4, 7, 9) . This strong effect of LPS is even more astonishing, as these three studies showed that 24 h after the LPS injection (i.e., at the beginning of MV), the proinflammatory cytokine production was almost back to normal and the morphological aspect of the lung was comparable to the CTRL animals. However, as the primary goal of this particular animal model is the analysis of the combined effect of the major risk factors for lung development impairment and BPD, we prioritized the direct comparison between the full treatment (LMVO) and the control (CTRL) group.
In summary, these gene array experiments identified mainly tissue modeling/wound repair and immune response pathways as being de novo or persistently modified 48 h after respiratory support. At this time point of recovery, mainly MMPs and complement factors show an altered expression pattern and may have an impact on lung development and the progression toward BPD. The implication of MMPs in many different pathways may indicate that their impact on lung 
METHODS
Animal Procedures
Pregnant Wistar rats (Charles River Laboratories, L' Arbresle Cedex, France) were housed in a controlled 12 h light-dark cycle room, with food and water ad libitum. Litter size was reduced to 8-10 pups at postnatal day 1 (P1) and kept constant during the experiment. Pups were marked and weighted every day, and males were randomly assigned to one of four groups: the controls (CTRL), the LPS-injected group (LPS), the group with LPS-injection and 6 h of MV with room air (LMV), and the group of LPS-injection and 6 h of MV with 60% oxygen (LMVO). All animals except controls received an i.p. injection of 2 mg/kg freshly prepared LPS E. coli serotype 026:B6 (Sigma-Aldrich, St Louis, MO) 24 h before MV. CTRLs were injected the same volume of NaCl 0.9%. At P5 or P6, pups of LMV and LMVO groups were anesthetized with a mixture of ketamine 38 mg/kg (Ketanarkon 100; Streuli, Uznach, Switzerland), acepromazine 0.76 mg/kg (Prequillan; Arovet AG, Zollikon, Switzerland), and atropine 0.06 mg/kg (Hanseler AG, Herisau, Switzerland). After an orotracheal intubation by direct laryngoscopy with a 24G i.v. catheter (Optiva W I.V.Catheter; Smiths Medical International, Rossendale, UK), the tube was connected to a rodent ventilator (Voltek Rodent Ventilator; Voltek Enterprises, Toronto, Canada) in volume-controlled mode with a tidal volume of 15 ml/kg, a respiratory rate of 25/min, and a inspiratory/expiratory time ratio of 1:3. Anesthesia was maintained by adding 1-2% of isoflurane (Provet AG, Lyssach, Switzerland) to the inspiratory circuit using a Combi-vet evaporator (Rothacher and Partner Electronics, Bern, Switzerland). During the entire experiment, heart rate (Hewlett-Packard, Dubendorf, Switzerland) was continuously monitored. Ventilated animals were kept on a heated blanket and maintained under a custom-made cover. Body temperature was measured with a rectal probe connected to a digital thermometer (Dynatime SA, La Chaux-de-Fonds, Switzerland) and remained quite stable at 35 ± 1 °C during the whole experiment. Nonventilated animals were set aside in a small box, covered with tissues, and body temperature was maintained within the same limits with a heating lamp. Fluid was supplied after 3 h of ventilation by i.p. injection of Ringer's lactate 10 ml/kg (Ri-lac; B. Braun Medical AG, Sempach, Switzerland). After 5½ h of MV, isoflurane was reduced in 2 to 3 steps over 30 min from baseline treatment (1-2%) to reach 0% at the end of the 6-h ventilation period. Ventilation parameters and oxygen were also reduced then, and the rat pups extubated as soon as spontaneous breathing reappeared, normally within minutes. Animals were returned to their mother when completely awake. Animals from the CTRL and LPS groups were also separated during 6 h from their mother by maintaining their body temperature at 34-36 °C, and they received one i.p. injection of Ringer lactate, too.
In preliminary experiments, the effect of MV on blood gases and the acid/base status of the animals were analyzed by performing arterial blood gas measurements. After either 1 or 6 h of MV, the carotid artery was prepared, cut, and the arterial blood collected into a capillary for blood gas measurement on a handheld blood gas analyzer (i-Stat 1; Abbott Point of Care, Princeton, NJ).
Institutional Review
All animal procedures were conducted according to the guidelines of the "Swiss Legislation for Animal Protection" act. The detailed protocol was approved by the responsible Veterinary Commission of the Canton of Vaud (authorization number: 1943.1).
Preparation of Lung Tissue and RNA Extraction
Lung harvest and preparation was done as described previously (7) . Total lung RNA was extracted with TRIzol (Invitrogen, Carlsbad, CA) following the standard protocol. After the extraction step, the supernatant was recovered, an equal volume of EtOH70% was added and the mix loaded onto RNeasy mini columns (Qiagen, Hilden, Germany). RNA was extracted according the Qiagen protocol.
Affymetrix Gene Array
Total RNA from nine rat lungs per group were used and pooled by three, leading to three gene arrays per group. All RNA quantities were assessed by NanoDropND-1000 spectrophotometer, and the RNA quality was assessed using RNA 6000 NanoChips with the Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA). For each sample, 100 ng of total RNA were amplified using the Ambion WT Expression Kit (4411973; Life Technologies, Lucerne, Switzerland). An amount of 5.5 µg cDNA was fragmented and labeled with GeneChip WT Terminal Labeling kit (901525; Affymetrix, Santa Clara, CA). Affymetrix rat gene 1.0ST arrays were hybridized with 2.3 µg of fragmented target, at 45 °C for 16 h, washed, and stained according to the protocol described in Affymetrix GeneChip Expression Analysis Manual (Fluidics protocol FS450_0007).
The arrays were scanned with the GeneChip Scanner 3000 7G (Affymetrix). Normalized expression signals were calculated from Affymetrix CEL files by the Robust Multi-array Average algorithm, using the Affymetrix Expression Console Software. Hybridization quality was assessed using Expression Console Software as well. All statistical analyses were performed using the free high-level interpreted statistical language R. Differential hybridized features were MMP12  5′-CGTCTCGATGTGGAGTGCCTGA-3′  5′-CCGCACGCTTCATGTCTGGAGT-3′   S100A8  5′-TGAGTGCCCTCAGTTTGTGCAGAA-3′  5′-GCTGCCACGCCCACCCTTATC-3′   S100A9  5′-ACAGGATCTCAGCTGGAGCGCA-3′  5′-TCCGCCTTGTTCAGGGTGTCAGG-3′   RETNLA  5′-CTGCCCTGCTGGGATGACTGCT-3′  5′-GTTGGCAGCAGCGGGCATAGG-3′   LCN2  5′-GGCAGCGAATGCGGTCCAGAAA-3′  5′-TGGCCCCTGACGAGGATGGAAG-3′   MMP8  5′-CCCTCCCAGTGCCTCCAGAACA-3′  5′-CTTGCAGACCGGAACTGATTGCT-3′   NOX4  5′-CTGCCCACTTGGTGAACGCCC-3′  5′-ACCTGTCAGGCCCGGAACAGT-3′   TIMP1  5′-TCCCAGAACCGCAGCGAGGA-3′  5′-ACTGTGCACACCCCACAGCC-3′ MMP9 5′-GTCCAGACCAAGGGTACAGC-3′ 5′-AGGGGAGTCCTCGTGGTAGT-3′ CAMP 5′-TGCAACCCCATAGGGACGTCC-3′ 5′-GCTGAGGGTCTGGGAAACGGC-3′ CHI3L1 5′-CCAGGCCGCTACACCAAGGAGA-3′ 5′-GCAAAGGGAACCTGCTGGCCAA-3′
